Chaudhuri K R, Pal S, DiMarco A, Whately-Smith C, Bridgman K, Mathew R, Pezzela F R, Forbes A, Högl B, Trenkwalder C
Department of Neurology, King's College Hospital, London SE5, UK.
J Neurol Neurosurg Psychiatry. 2002 Dec;73(6):629-35. doi: 10.1136/jnnp.73.6.629.
No formal instruments are available for quantifying sleep problems in Parkinson's disease.
To develop a new sleep scale to quantify the various aspects of nocturnal sleep problems in Parkinson's disease, which may occur in up to 96% of affected individuals.
Employing a multidisciplinary team approach, a visual analogue scale was devised addressing 15 commonly reported symptoms associated with sleep disturbance in Parkinson's disease-the Parkinson's disease sleep scale (PDSS). In all, 143 patients with Parkinson's disease completed the PDSS, covering the entire spectrum of disease from newly diagnosed to advanced stage. As controls, 137 age healthy matched subjects also completed the scale. Test-retest reliability was assessed in a subgroup of subjects. The Epworth sleepiness scale was also satisfactorily completed by 103 of the patients with Parkinson's disease.
PDSS scores in the Parkinson group were significantly different from the healthy controls. Patients with advanced Parkinson's disease had impaired scores compared with early/moderate disease. Individual items of the scale showed good discriminatory power between Parkinson's disease and healthy controls. Relevant items of the PDSS correlated with excessive daytime sleepiness. The scale showed robust test-retest reliability.
This appears to be the first description of a simple bedside screening instrument for evaluation of sleep disturbances in Parkinson's disease. A combination of subitems may help identify specific aspects of sleep disturbance, which in turn may help target treatment.
目前尚无用于量化帕金森病睡眠问题的正式工具。
开发一种新的睡眠量表,以量化帕金森病夜间睡眠问题的各个方面,这些问题在高达96%的患者中可能出现。
采用多学科团队方法,设计了一种视觉模拟量表,该量表针对帕金森病中15种常见的与睡眠障碍相关的症状——帕金森病睡眠量表(PDSS)。共有143例帕金森病患者完成了PDSS,涵盖了从新诊断到晚期的整个疾病范围。作为对照,137名年龄匹配的健康受试者也完成了该量表。在一个亚组受试者中评估了重测信度。103例帕金森病患者也令人满意地完成了爱泼华嗜睡量表。
帕金森病组的PDSS评分与健康对照组有显著差异。晚期帕金森病患者的评分与早期/中期疾病患者相比有所受损。该量表的各个项目在帕金森病患者和健康对照组之间显示出良好的区分能力。PDSS的相关项目与日间过度嗜睡相关。该量表显示出较强的重测信度。
这似乎是首次描述一种用于评估帕金森病睡眠障碍的简单床边筛查工具。子项目的组合可能有助于识别睡眠障碍的具体方面,进而有助于确定治疗靶点。